Lignans Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Lignans Market was valued at USD 77.03 billion and will grow at 5.8% CAGR from 2024 to 2032. The robust growth is largely attributed to increasing consumer awareness of health and wellness benefits. Celebrated for their antioxidant and anti-inflammatory properties, these phytochemicals are carving a niche in the nutraceutical and functional food sectors.

Demand for natural and organic ingredients is on the rise, further propelled by research highlighting lignans' potential in disease prevention and management, particularly for hormone-related ailments. According to a report by the Global Wellness Institute, the wellness economy grew by 6.4% annually from 2017 to 2022, underscoring the increasing consumer focus on health.

With consumers prioritizing health and wellness, the lignans industry is experiencing notable growth. This uptick is primarily driven by a heightened interest in natural supplements and functional foods, especially those rich in lignans, which are lauded for their cardiovascular and hormone-balancing benefits. Furthermore, advancements in extraction methods are boosting the purity and efficacy of lignan products, a fact that's being reinforced by regulatory approvals and scientific validation. For instance, a study published in the Journal of Food Science and Technology in 2023 highlighted the improved extraction techniques that enhance lignan bioavailability.

The overall lignans Industry is categorized based on source, application, and region.

The market categorizes source into oilseeds, cereals, plant resins. The oil seeds-based segment is set to reach USD 107.11 billion by 2032, showcasing a 5.9% CAGR. Oil seeds, particularly flaxseeds, sesame seeds, and sunflower seeds, dominate the market due to their high lignan content and bioavailability. Celebrated for their antioxidant and anti-inflammatory properties, these compounds find extensive use in food products, supplements, and nutraceuticals, driving the substantial market share of oil seeds.

The application segment is categorized into cosmetics, animal feed, pharmaceuticals and food. The food segment accounted for 50% of the market share, translating to USD 15.19 billion. Projections indicate a growth rate of 5.7% CAGR from 2024 to 2032. Lignans are integral to a variety of food items, including pasta, cereals, whole grain breads, energy bars, crackers, snack foods, and meatless products, imparting estrogenic and antioxidant properties.

Asia Pacific lignans market is on track to reach USD 42.58 billion, with a projected CAGR of 5.4% from 2024 to 2032. This growth is fuelled by rising consumer awareness of lignans' health benefits, such as their potential to reduce chronic disease risks and promote overall wellness. Countries like China, Japan, and India are leading this shift towards natural and organic supplements, solidifying the region's prominence.

Product Code: 4594

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Base estimates and calculations
1.3 Forecast calculation
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Key manufacturers
- 3.1.2 Distributors
- 3.1.3 Profit margins across the industry
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 North America Growing health concerns
  - 3.2.1.2 Europe Strong pharmaceutical sector
  - 3.2.1.3 Asia Pacific Growing animal feed industry
- 3.2.2 Market challenges
  - 3.2.2.1 Lack of product awareness
  - 3.2.2.2 Regulatory Variability
- 3.2.3 Market opportunity
  - 3.2.3.1 New opportunities
  - 3.2.3.2 Growth potential analysis
3.3 Raw material landscape
- 3.3.1 Manufacturing trends
- 3.3.2 Technology evolution
  - 3.3.2.1 Sustainable manufacturing
    - 3.3.2.1.1 Green practices
    - 3.3.2.1.2 Decarbonization
- 3.3.3 Sustainability in raw materials
- 3.3.4 Pricing trends (USD/Tons), 2021 - 2032
  - 3.3.4.1 North America
  - 3.3.4.2 Europe
  - 3.3.4.3 Asia Pacific
  - 3.3.4.4 Latin America
  - 3.3.4.5 Middle East and Africa
3.4 Regulations and market impact
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Company market share analysis
4.2 Competitive positioning matrix
4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)

5.1 Key trends
5.2 Oilseeds
5.3 Cereals
5.4 Plant resins

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

6.1 Key trends
6.2 Food
6.3 Cosmetics
- 6.3.1 Skin Care
- 6.3.2 Hair care
- 6.3.3 Toiletries
- 6.3.4 Others
6.4 Animal Feed
- 6.4.1 Ruminants
- 6.4.2 Horses
- 6.4.3 Others
6.5 Pharmaceuticals
- 6.5.1 Estrogen related health diseases
- 6.5.2 Cardiovascular disease
- 6.5.3 Others

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 India
- 7.4.3 Japan
- 7.4.4 South Korea
- 7.4.5 Australia
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 MEA
- 7.6.1 Saudi Arabia
- 7.6.2 UAE
- 7.6.3 South Africa
- 7.6.4 Rest of MEA

Chapter 8 Company Profiles

8.1 Henkel
8.2 TSKG
8.3 Natural Ingredient Bio-Resources
8.4 Prairie Tide Diversified
8.5 Biogin
8.6 Shaanxi Zebrago Industrial
8.7 Xian Lyphar Biotech
8.8 Natural Ingredient Bio-Resources, Limited
8.9 Dongguan Meiherb Biotech
8.10 VNI bioscience
8.11 Zebrago Herb
8.12 Hunan NutraMax
8.13 Kingherbs Hanzhong Penghong Tianyi Biotech Co., Ltd
8.14 Naturalin Bio-Resources Co., Ltd.
8.15 Ningbo United Plant Technology Co., Ltd.
8.16 Hebei Xinqidian Biotechnology Co., Ltd.
8.17 Skuny Bioscience Co., Ltd.
8.18 Shaanxi Sinuote Biotech Co., Ltd.
8.19 Xi'an Qingshuo Import and Export Trade Co., Ltd
8.20 Wuxi Gorunjie Natural-Pharma Co., Ltd
8.21 Xi'an Contri Biological Technology Co., Ltd
8.22 Hangzhou Excelente
8.23 Beijing UE Biotech Co., Ltd
8.24 FarmaSino Pharmaceuticals